Kawasumi Laboratories Inc. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
27,625
28,408
28,135
24,726
25,437
24,104
Cost of Goods Sold (COGS) incl. D&A
18,975
18,878
18,006
15,865
16,754
15,917
Gross Income
8,650
9,530
10,129
8,861
8,683
8,187
SG&A Expense
8,402
8,123
7,999
7,937
7,995
7,609
EBIT
248
1,407
2,130
924
688
578
Unusual Expense
644
80
-
-
-
1,671
Non Operating Income/Expense
246
393
41
2
9
1,441
Interest Expense
45
2
1
1
1
1
Pretax Income
1,085
1,749
2,160
1,017
733
409
Income Tax
457
747
966
123
283
220
Consolidated Net Income
628
1,002
1,194
1,140
449
188
Net Income
606
975
1,167
1,116
440
187
Net Income After Extraordinaries
606
975
1,167
1,116
440
187
Net Income Available to Common
606
975
1,167
1,116
440
186
EPS (Basic)
26.53
42.64
51.47
51.16
20.17
8.83
Basic Shares Outstanding
23
23
23
22
22
21
EPS (Diluted)
26.50
42.64
51.47
51.16
20.17
8.83
Diluted Shares Outstanding
23
23
23
22
22
21
EBITDA
2,945
3,515
3,963
2,544
2,377
2,209
Non-Operating Interest Income
9
14
31
35
40
49
Minority Interest Expense
22
27
27
24
9
1
Equity in Affiliates (Pretax)
17
17
41
56
15
13
About Kawasumi Laboratories
View Profile
